Skip to main content



05-01-2018 | Glyburide | Highlight | News

Glyburide ‘not justified’ as first-line gestational diabetes treatment

A head-to-head trial in women with gestational diabetes has failed to prove that glyburide is statistically noninferior to insulin in terms of perinatal outcomes.

02-09-2018 | Gestational diabetes | News

High macrosomia risk with early gestational diabetes diagnosis

Women who are diagnosed with gestational diabetes within the first 24 weeks of pregnancy are at particularly high risk for delivering a baby that is large for its gestational age, say researchers.

01-26-2017 | Gestational diabetes | News

Combining oral agents could reduce insulin need in gestational diabetes

Glyburide and metformin are comparable treatments for gestational diabetes, and their combination reduces the need for insulin after treatment failure, results of a randomized trial suggest.

Read more

Related topics



Journal articles and book chapters

05-24-2018 | Gliclazide | Review | Article

The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents

Colagiuri S et al. Diabetes Res Clin Prac 2018. doi: 10.1016/j.diabres.2018.05.028

05-18-2018 | Type 2 diabetes | Review | Article

Combination glucose-lowering therapy plans in T2DM: Case-based considerations

Blonde L, Dipp S, Cadena D. Adv Ther 2018. doi: 10.1007/s12325-018-0694-0

05-08-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: Do oral agents have a place?

Corcoy R et al. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.015